pyrazolanthrone has been researched along with Cirrhosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barati, MT; Cai, L; Jin, S; Li, J; Lin, Q; Rane, MJ; Rane, S; Tan, Y | 1 |
| Chen, BC; Chen, CL; Cheng, WH; Kao, SY; Lin, CH; Lin, LY; Yuliani, FS | 1 |
| Jia, Y; Li, Y; Liu, X; Song, Y; Wang, J; Wu, H; Zhang, H; Zhou, S | 1 |
| Ikeda, K; Kanno, Y; Kawashita, E; Kokado, A; Kuretake, H; Matsuno, H; Matsuo, O; Okada, K; Seishima, M; Ueshima, S | 1 |
| Bulut, G; Dönmez, YB; Erten, R; Kurdoglu, M; Kurdoglu, Z | 1 |
| Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
| Chen, W; Dong, X; Liu, Q; Mao, H; Nie, J; Yang, Q; Yu, X | 1 |
| Bonne, G; Muchir, A; Shan, J; Worman, HJ; Wu, W | 1 |
| Akita, Y; Enoki, C; Fujiwara, H; Imamura, H; Iwasaka, T; Kamihata, H; Kyoi, S; Matsuhisa, S; Otani, H; Tatsumi, K | 1 |
| Chizzolini, C; Dayer, JM; Fineschi, S; Guerne, PA; Reith, W | 1 |
10 other study(ies) available for pyrazolanthrone and Cirrhosis
| Article | Year |
|---|---|
ERK and p38 MAPK inhibition controls NF-E2 degradation and profibrotic signaling in renal proximal tubule cells.
Topics: Animals; Anthracenes; Cell Line, Transformed; Cysteine Proteinase Inhibitors; Female; Fibrosis; Humans; Kidney Tubules, Proximal; Leupeptins; MAP Kinase Signaling System; Mice; Mice, Transgenic; NF-E2 Transcription Factor, p45 Subunit; p38 Mitogen-Activated Protein Kinases | 2021 |
Amphiregulin induces CCN2 and fibronectin expression by TGF-β through EGFR-dependent pathway in lung epithelial cells.
Topics: Amphiregulin; Animals; Asthma; Epithelial Cells; Epithelial-Mesenchymal Transition; ErbB Receptors; Fibronectins; Fibrosis; Humans; Lung; Mice; Ovalbumin; RNA, Small Interfering; Transcription Factor AP-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
SP600125 suppresses
Topics: Albuminuria; Animals; Anthracenes; Cell Nucleus; Diabetic Nephropathies; Fibrosis; Gene Deletion; Glucose; Inflammation; JNK Mitogen-Activated Protein Kinases; Kelch-Like ECH-Associated Protein 1; Kidney; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Protein Transport; RNA, Small Interfering | 2018 |
α2AP mediated myofibroblast formation and the development of renal fibrosis in unilateral ureteral obstruction.
Topics: alpha-2-Antiplasmin; Animals; Anthracenes; Cell Differentiation; Epithelial Cells; Fibrosis; Gene Expression Regulation; Kidney; Male; MAP Kinase Kinase 4; Mesenchymal Stem Cells; Mice; Mice, Knockout; Myofibroblasts; Primary Cell Culture; Protein Kinase Inhibitors; Renal Insufficiency; Signal Transduction; Transforming Growth Factor beta; Ureter; Ureteral Obstruction | 2014 |
Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome.
Topics: Animals; Anthracenes; Disease Models, Animal; Female; Fibrosis; Immunohistochemistry; Inflammation; MAP Kinase Kinase 4; Polycystic Ovary Syndrome; Protein Kinase Inhibitors; Rats; Rats, Wistar | 2015 |
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |
Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
Topics: Actins; Animals; Anthracenes; Cadherins; Collagen Type I; Epithelial Cells; Fibrosis; Gene Expression Regulation; JNK Mitogen-Activated Protein Kinases; Male; Peritoneal Diseases; Peritoneum; Phosphorylation; Rats; Rats, Sprague-Dawley; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2008 |
Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene.
Topics: Animals; Anthracenes; Cardiomyopathy, Dilated; Fibrosis; Flavonoids; Heart Function Tests; Lamin Type A; Male; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Mutation; Myocardium; Pilot Projects; Protein Kinase Inhibitors | 2011 |
Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster.
Topics: Animals; Anthracenes; Apoptosis; Cardiomyopathy, Dilated; Cricetinae; Fibrosis; Imidazoles; Immunoblotting; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Male; Microscopy, Fluorescence; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Ventricular Dysfunction, Left | 2006 |
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
Topics: Acetylcysteine; Anthracenes; Boronic Acids; Bortezomib; Collagen Type I; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Matrix; Fibroblasts; Fibrosis; Genes, jun; Humans; JNK Mitogen-Activated Protein Kinases; Leupeptins; Matrix Metalloproteinase 1; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-jun; Pyrazines; RNA Polymerase II; RNA, Messenger; Scleroderma, Systemic; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Up-Regulation | 2006 |